Earl D. Silverman

Active 1983–2025

115
Papers
17,928
Citations
83
h-index
114
i10-index

Citations

Citations per year for Earl D. Silverman1985: 1 citations1987: 3 citations1988: 1 citations1989: 2 citations1990: 5 citations1991: 2 citations1992: 7 citations1993: 13 citations1994: 8 citations1995: 10 citations1996: 11 citations1997: 13 citations1998: 15 citations1999: 16 citations2000: 29 citations2001: 34 citations2002: 49 citations2003: 60 citations2004: 77 citations2005: 109 citations2006: 76 citations2007: 93 citations2008: 115 citations2009: 134 citations2010: 186 citations2011: 186 citations2012: 153 citations2013: 114 citations2014: 115 citations2015: 122 citations2016: 119 citations2017: 104 citations2018: 150 citations2019: 437 citations2020: 358 citations2021: 353 citations2022: 267 citations2023: 154 citations2024: 257 citations2025: 83 citations2026: 3 citations1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,264 citing papers, 23.4% of this breakdownUnited Kingdom: 480 citing papers, 8.9% of this breakdownCanada: 451 citing papers, 8.4% of this breakdownItaly: 324 citing papers, 6% of this breakdownGermany: 268 citing papers, 5% of this breakdownChina: 198 citing papers, 3.7% of this breakdownNetherlands: 190 citing papers, 3.5% of this breakdownFrance: 188 citing papers, 3.5% of this breakdownSpain: 135 citing papers, 2.5% of this breakdownAustralia: 117 citing papers, 2.2% of this breakdownSweden: 102 citing papers, 1.9% of this breakdownBrazil: 101 citing papers, 1.9% of this breakdown
0%23.4%Other 29.1%

Fields

  • Medicine77.7%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Immunology and Microbiology5.6%
  • Neuroscience1.3%
  • Health Professions0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Other0.8%

Topics

  • Systemic Lupus Erythematosus Research10.9%
  • Autoimmune and Inflammatory Disorders Research8.3%
  • Rheumatoid Arthritis Research and Therapies4.6%
  • Adolescent and Pediatric Healthcare3%
  • Ocular Diseases and Behçet’s Syndrome2.8%
  • Genomics and Rare Diseases2.8%
  • Other67.6%

Coauthors

All papers

Open in search
  1. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saadet Mercimek‐Andrews, Roberto Mendoza‐Londono, Tino D. Piscione, Rayfel Schneider, Andreas Schulze, Earl D. Silverman, Komudi Siriwardena, O. Carter Snead, Neal Sondheimer, Joanne Sutherland, Ajoy Vincent, Jonathan D. Wasserman, Rosanna Weksberg, Cheryl Shuman, Chris Carew, Michael J. Szego, Robin Z. Hayeems, Raveen Basran, Dimitri J. Stavropoulos, Peter N. Ray, Sarah Bowdin, M. Stephen Meyn, Ronald D. Cohn, Stephen W. Scherer, Christian R. Marshall - Genetics in Medicine 2017 cited by 565

  2. Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosus

    Authors: , , , , - Arthritis & Rheumatism 2008 cited by 556

  3. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aimée L Fenwick, Jonathan Flint, Lars Fugger, Rodney D. Gilbert, Anne Goriely, Angie Green, Ingo H. Greger, Russell Grocock, Anja V. Gruszczyk, Robert Hastings, Edouard Hatton, Douglas R. Higgs, Adrian V. S. Hill, Chris Holmes, Malcolm F. Howard, Linda Hughes, Peter Humburg, David H. Johnson, Fredrik Karpe, Zoya Kingsbury, Usha Kini, Julian C. Knight, Jonathan Krohn, Sarah Lamble, Craig B. Langman, Lorne Lonie, Joshua Luck, Davis J. McCarthy, Simon J. McGowan, Mary Frances McMullin, Kerry A. Miller, Lisa Murray, Andrea H. Németh, M. Andrew Nesbit, David Nutt, Elizabeth Ormondroyd, Annette Oturai, Alistair T. Pagnamenta, Smita Y. Patel, Melanie J. Percy, Nayia Petousi, Paolo Piazza, Siân E. Piret, Guadalupe Polanco‐Echeverry, Niko Popitsch, Fiona Powrie, Christopher W. Pugh, Lynn Quek, Peter A. Robbins, Kathryn Robson, Alexandra Russo, Natasha Sahgal, Pauline A. van Schouwenburg, Anna Schuh, Earl D. Silverman, Alison Simmons, Per Soelberg Sørensen, Elizabeth Sweeney, John Taylor, Rajesh V. Thakker, Ian Tomlinson, Amy Trebes, Stephen R.F. Twigg, Holm H. Uhlig, Paresh Vyas, Tim J. Vyse, Steven A. Wall, Hugh Watkins, Michael P. Whyte, Lorna Witty and 10 more - Nature Genetics 2015 cited by 388

  4. Prevalence and burden of pediatric-onset systemic lupus erythematosus

    Authors: , - Nature Reviews Rheumatology 2010 cited by 358

  5. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase

    Authors: , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 185

  6. Clinical and Laboratory Characteristics and Long-Term Outcome of Pediatric Systemic Lupus Erythematosus: A Longitudinal Study

    Authors: , , , , , - The Journal of Pediatrics 2007 cited by 368

  7. The Importance of the Level of Maternal Anti-Ro/SSA Antibodies as a Prognostic Marker of the Development of Cardiac Neonatal Lupus Erythematosus

    Authors: , , , , - Journal of the American College of Cardiology 2010 cited by 269

  8. Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood‐Onset Systemic Lupus Erythematosus

    Authors: , , , , - Arthritis & Rheumatology 2018 cited by 95

  9. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE

    Authors: , , , , , , , , , , , - Lara D. Veeken 2019 cited by 58

  10. Use of atorvastatin in systemic lupus erythematosus in children and adolescents

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2011 cited by 173

  11. Ethnic Differences in Pediatric Systemic Lupus Erythematosus

    Authors: , , , , , - The Journal of Rheumatology 2009 cited by 173

  12. Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Rheumatology 2020 cited by 34

  13. Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis

    Authors: , , , , , , , , , - The Journal of Rheumatology 2020 cited by 28

  14. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Graciela Espada, Roger Allen, Jeffrey Chaitow, Rik Joos, Carine Wouters, Sheila Knupp, Flavio Sztajnbok, David Cabral, Kristin Houghton, Johannes Roth, Heinrike Schmeling, Chantal Job-Deslandre, Christian Jorgensen, Isabelle Kone Paut, Kirsten Minden, Frank Weller-Heinemann, Valeria Gerloni, Francesco Zulian, Ruben Burgos-Vargas, Carolina Duarte Salazar, Eunice Solis-Vallejo, Armando Calvo, José Chavez, Manuel Ferrandiz Zavaler, Anna Gruenpeter, Katarzyna Kobusinska, Alexey Sarychev, Elena Zholobova, Athimalaipet Ramanan, Patricia Woo, Steven Goodman, Abraham Gedalia, Yukiko Kimura, Karen Onel, Kenneth Schikler - Annals of the Rheumatic Diseases 2014 cited by 314

  15. The role of antimalarial agents in the treatment of SLE and lupus nephritis

    Authors: , , - Nature Reviews Nephrology 2011 cited by 242

  16. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ornella J. Rullo, Natasha M. Ruth, Laura E. Schanberg, Earl D. Silverman, Nora G. Singer, Jennifer B. Soep, Reema Syed, Larry B. Vogler, Ali Yalçindağ, Cagri Yildirim‐Toruner, Carol A. Wallace, Hermine I. Brunner - Arthritis Care & Research 2011 cited by 194

  17. A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Beutler, Greg Keenan, Jason Clark, Sudha Visvanathan, Adedigbo A. Fasanmade, Aparna Raychaudhuri, Alan Mendelsohn, Alberto Martini, Edward H. Giannini - Arthritis & Rheumatism 2007 cited by 411

  18. Risk factors for damage in childhood‐onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage

    Authors: , , , , - Arthritis & Rheumatism 2002 cited by 318

  19. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: Ethnicity as a risk factor

    Authors: , , , , , , - Arthritis & Rheumatism 2007 cited by 285

  20. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 240

  21. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel J. Lovell, Alberto Martini - Annals of the Rheumatic Diseases 2017 cited by 128

  22. Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2000 cited by 1,252

  23. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: A long‐term followup study

    Authors: , , , , , , - Arthritis & Rheumatism 2007 cited by 289

  24. Incidence and spectrum of neonatal lupus erythematosus: A prospective study of infants born to mothers with anti-Ro autoantibodies

    Authors: , , , - The Journal of Pediatrics 2003 cited by 282